Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Brain : a Journal of Neurology
|
October 4, 2020
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes
Ruth Brauer, Li Wei, Tiantian Ma, et al.
Movement Disorders Clinical Practice
|
February 5, 2019
Thalamic-Caudal Zona Incerta Deep Brain Stimulation for Refractory Orthostatic Tremor: A Report of 3 Cases
Dilan Athauda, Dejan Georgiev, Iciar Aviles-Olmos, et al.
The European Journal of Neuroscience
|
August 3, 2018
Post hoc analysis of the Exenatide-PD trial-Factors that predict response
Dilan Athauda, Kate Maclagan, Natalia Budnik, et al.
Journal of Parkinson'S Disease
|
May 31, 2018
What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson's Disease: A Post Hoc Analysis
Dilan Athauda, Kate Maclagan, Natalia Budnik, et al.
Journal of Neurosurgery
|
October 19, 2023
Clinical outcomes after MRI connectivity-guided radiofrequency thalamotomy for tremor
Thomas Wirth, Taco Goedemans, Ali Rajabian, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 2, 2019
Short Versus Conventional Pulse-Width Deep Brain Stimulation in Parkinson's Disease: A Randomized Crossover Comparison
Viswas Dayal, Timothy Grover, Elina Tripoliti, et al.
Journal of Parkinson'S Disease
|
August 5, 2017
GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort
Vanessa Lythe, Dilan Athauda, Jennifer Foley, et al.
JAMA Neurology
|
January 15, 2019
Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial
Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati, et al.
Movement Disorders Clinical Practice
|
August 22, 2024
Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early- to Mid-Stage Parkinson's Disease Modification Trials
Nirosen Vijiaratnam, Christine Girges, Dilan Athauda, et al.
Clinical Trials (London, England)
|
December 1, 2025
Mild-to-moderate depressive symptoms impact on self-reported outcome measures in clinical trials for neurodegenerative diseases
Christine Girges, Nirosen Vijiaratnam, Alexa King, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Brain : a Journal of Neurology
|
October 4, 2020
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes
Ruth Brauer, Li Wei, Tiantian Ma, et al.
Movement Disorders Clinical Practice
|
February 5, 2019
Thalamic-Caudal Zona Incerta Deep Brain Stimulation for Refractory Orthostatic Tremor: A Report of 3 Cases
Dilan Athauda, Dejan Georgiev, Iciar Aviles-Olmos, et al.
The European Journal of Neuroscience
|
August 3, 2018
Post hoc analysis of the Exenatide-PD trial-Factors that predict response
Dilan Athauda, Kate Maclagan, Natalia Budnik, et al.
Journal of Parkinson'S Disease
|
May 31, 2018
What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson's Disease: A Post Hoc Analysis
Dilan Athauda, Kate Maclagan, Natalia Budnik, et al.
Journal of Neurosurgery
|
October 19, 2023
Clinical outcomes after MRI connectivity-guided radiofrequency thalamotomy for tremor
Thomas Wirth, Taco Goedemans, Ali Rajabian, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 2, 2019
Short Versus Conventional Pulse-Width Deep Brain Stimulation in Parkinson's Disease: A Randomized Crossover Comparison
Viswas Dayal, Timothy Grover, Elina Tripoliti, et al.
Journal of Parkinson'S Disease
|
August 5, 2017
GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort
Vanessa Lythe, Dilan Athauda, Jennifer Foley, et al.
JAMA Neurology
|
January 15, 2019
Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial
Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati, et al.
Movement Disorders Clinical Practice
|
August 22, 2024
Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early- to Mid-Stage Parkinson's Disease Modification Trials
Nirosen Vijiaratnam, Christine Girges, Dilan Athauda, et al.
Clinical Trials (London, England)
|
December 1, 2025
Mild-to-moderate depressive symptoms impact on self-reported outcome measures in clinical trials for neurodegenerative diseases
Christine Girges, Nirosen Vijiaratnam, Alexa King, et al.
Page
of 6